Expression of mouse mammary tumor virus envelope protein does not prevent superinfection in vivo or in vitro

Virology

Volumn 263, Issue 2, 1999, Pages 418-426

  Dzuris, John L ^a   Zhu, Wei ^a   Kapkov, Denis ^a   Golovkina, Tatyana V ^a   Ross, Susan R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVIRUS; SUPERINFECTION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS INFECTION;

ANIMALIA; DNA VIRUSES; EXOGENOUS MOUSE MAMMARY TUMOR VIRUS; MAMMARY TUMOR ONCOVIRUS; MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS; ONCOVIRINAE; RNA VIRUSES; TUMOR VIRUS;

EID: 0033604291     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9967     Document Type: Article

References (41)

1. Acha-Orbea H., Shakhov A. N., Scarpellino L., Kolb E., Muller V., Vessaz-Shaw A., Fuchs R., Blochlinger K., Rollini P., Billotte J., Sarafidou M., MacDonald H. R., Diggelman H. Clonal deletion of Vβ14-bearing T cells in mice transgenic for mammary tumor virus. Nature. 350:1991;207-210.
2. Ardavin C., Luthi F., Andersson M., Scarpellino L., Martin P., Diggelmann H., Acha-Orbea H. Retrovirus-induced target cell activation in the early phases of infection: The mouse mammary tumor virus model. J. Virol. 71:1997;7295-7299.
3. Baillet J. W., Berson J., D'Cruz C. M., Huang J., Crane J., Gilbert J. M., Bates P. Production and characterization of a soluble, active form of Tva, the subgroup A avian sarcoma and leukosis virus receptor. J. Virol. 73:1999;3054-3061.
4. Beutner U., Draus E., Kitamura D., Rajewsky K., Huber B. T. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179:1994;1457-1466.
5. Chesebro B., Wehrly K. Different murine cell lines manifest unique patterns of interference to superinfection by murine leukemia viruses. Virology. 141:1985;119-129.
6. Choi Y., Kappler J. W., Marrack P. A super antigen encoded in the open reading frame of the 3′ long terminal repeat of the mouse mammary tumor virus. Nature. 350:1991;203-207.
7. Cloyd M. W., Thompson M. M., Hartley J. W. Host range of mink cell focus-inducing viruses. Virology. 140:1985;239-248.
8. -r. J. Virol. 61:1987;308-314.
9. Delwart E. L., Panganiban A. T. Role of reticuloendotheliosis virus envelope glycoprotein in superinfection resistance. J. Virol. 63:1989;273-280.
10. b BALB/c mice. Int. Immunol. 5:1993;217-221.
11. Dyson P. J., Knight A. M., Fairchild S., Simpson E., Tomonari K. Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomes. Nature. 349:1991;531-532.
12. Dzuris J. L., Golovkina T. V., Ross S. R. Both T and B cells shed infectious MMTV. J. Virol. 71:1997;6044-6048.
13. Frankel W. N., Rudy C., Coffin J. M., Huber B. T. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature. 349:1991;526-528.
14. Golovkina T. V., Chervonsky A., Dudley J. P., Ross S. R. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell. 69:1992;637-645.
15. Golovkina T. V., Chervonsky A., Prescott J. A., Janeway C. A., Ross S. R. The mouse mammary tumor virus envelope gene product is required for superantigen presentation to T cells. J. Exp. Med. 179:1994;439-446.
16. Golovkina T. V., Dudley J. P., Jaffe A., Ross S. R. Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection. Proc. Natl. Acad. Sci. USA. 92:1995;4828-4832.
17. Golovkina T. V., Dzuris J. L., van den Hoogen B., Jaffe A. B., Wright P. C., Cofer S. M., Ross S. R. A novel membrane protein is a mouse mammary tumor virus receptor. J. Virol. 72:1998;3066-3071.
18. Golovkina T. V., Jaffe A. B., Ross S. R. Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range. J. Virol. 68:1994;5019-5026.
19. Golovkina T. V., Piazzon I., Nepomnaschy I., Buggiano V., de Olano Vela M., Ross S. R. Generation of a tumorigenic milkborne mouse mammary tumor virus by recombination between endogenous and exogenous viruses. J. Virol. 71:1997;3895-3903.
20. Golovkina T. V., Prescott J. A., Ross S. R. Mouse mammary tumor virus-induced tumorigenesis in sag transgenic mice: A laboratory model of natural selection. J. Virol. 67:1993;7690-7694.
21. Heard J. M., Danos O. An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J. Virol. 65:1991;4026-4032.
22. + T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J. Exp. Med. 177:1993;359-366.
23. Karapetian O., Shakhov A. N., Kraehenbuhl J. P., Acha-Orbea H. Retroviral infection of neonatal Peyer's patch lymphocytes: The mouse mammary tumor virus model. J. Exp. Med. 180:1994;1511-1516.
24. Kozak C. Susceptibility of wild mouse cells to exogenous infection with xenotropic leukemia viruses: Control by a single dominant locus on chromosome. J. Virol. 55:1985;690-695.
25. Limjoco T. I., Dickie P., Ikeda H., Silver J. Transgenic Fv-4 mice resistant to Friend virus. J. Virol. 67:1993;4163-4168.
26. Majors J. E., Varmus H. E. Nucleotide sequencing of an apparent proviral copy of env mRNA defines determinants of expression of the mouse mammary tumor virus env gene. J. Virol. 47:1983;495-504.
27. Marrack P., Kushnir E., Kappler J. A maternally inherited superantigen encoded by mammary tumor virus. Nature. 349:1991;524-526.
28. Michalides R., van Deemter L., Nusse R., van Nie R. Identification of the MMTV2 gene responsible for early appearance of mammary tumors in the GR mouse by nucleic acid hybridization. Proc. Natl. Acad. Sci. USA. 75:1978;2368-2372.
29. Miller A. D., Wolgamot G. Murine retroviruses use at least six different receptors for entry into Mus dunni cells. J. Virol. 71:1997;4531-4535.
30. Morris D. W., Young L. J. T., Gardner M. B., Cardiff R. D. Transfer, by selective breeding, of the pathogenic MMTV-2 endogenous provirus from the GR strain to a wild mouse line free of endogenous and exogenous mouse mammary tumor virus. J. Virol. 58:1986;247-252.
31. Nandi S., McGrath C. M. Mammary neoplasia in mice. Adv. Cancer Res. 17:1973;353-414.
32. Nusse R. The int genes in mammary tumorigenesis and in normal development. TIG. 4:1988;291-295.
33. Peters G. Inappropriate expression of growth factor genes in tumors induced by mouse mammary tumor virus. Semin. Virol. 2:1991;319-328.
34. Rein A. Interference grouping of murine leukemia viruses: A distinct receptor for the MCF-recombinant viruses in mouse cells. Virology. 120:1982;251-257.
35. Rein A., Schultz A. Different recombinant murine leukemia viruses use different cell surface receptors. Virology. 136:1984;144-152.
36. Shackleford G. M., Varmus H. E. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc. Natl. Acad. Sci. USA. 85:1988;9655-9659.
37. Sommerfelt M. A., Weiss R. A. Receptor interference groups of 20 retroviruses plating on human cells. Virology. 176:1990;58-69.
38. Soneoka Y., Cannon P. M., Ramsdale E. E., Griffiths J. C., Romano G., Kingsman S. M., Kingsman A. J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:1995;628-633.
39. + cells: Mechanism for persistence in AIDS. Cell. 53:1988;483-496.
40. Stoye J. P., Moroni C., Coffin J. M. Virological events leading to spontaneous AKR thymomas. J. Virol. 65:1991;1273-1285.
41. Woodland D. L., Happ M. P., Gollob K. J., Palmer E. An endogenous retrovirus mediating deletion of αβ T cells. Nature. 349:1991;529-530.